Deficiency can lead to megaloblastic anaemia and neurological complications
Success requires matching peptide mechanisms to disease pathology, using adequate doses achieving receptor engagement, maintaining treatment long enough for effects manifesting, combining complementary mechanisms for complex diseases, and monitoring mechanism-relevant outcomes documenting engagement
intravenous TB-4 Phase 1 safety and pharmacokinetics, no dose-limiting or serious adverse events (Ann N Y Acad Sci 2010;1194:223229): NCT00743769 Centers for Disease Control and Prevention
Moreover, a distinct OL population (peri-neuronal OL) has been identified in gray matter regions 81
GLP-1s are a family of drugs that youve certainly heard of because they include the diabetes drug Ozempic, also known as Wegovy when its used for weight loss
Compounded Semaglutide Safety Alert - Health Canada Health Canada position on unapproved compounded GLP-1 products and reported safety issues